Skip to search formSkip to main contentSkip to account menu

vanishing bile duct syndrome

Known as: bile duct syndrome vanishing 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: Efavirenz (Sustiva®) is used for the treatment of human immunodeficiency virus (HIV) type 1 infection. Hepatoxicity… 
2018
2018
Vanishing bile duct syndrome (VBDS) is a rare entity of acquired disorders resulting in cholestasis secondary to progressive… 
2017
2017
Vanishing bile duct syndrome (VBDS) manifests as progressive destruction and disappearance of the intrahepatic bile duct caused… 
2010
2010
Vanishing bile duct syndrome (VBDS) encompasses a group of different cholestatic liver diseases characterized by the destruction… 
2008
2008
A 37 year old black woman is described with difficult-to-control diabetes (DM), morbid obesity, hypertension, and chronic skin… 
2002
2002
Carbamazepine, a widely used anticonvulsant, can induce hepatotoxicity, usually evolving with an acute hepatitis that ceases… 
2000
2000
Abstract We present two distinct types of cholestatic syndrome identified in eight renal transplant (RTx) patients with HCV… 
1996
1996
Abstract  Cytomegalovirus (CMV) infection and HLA‐DR sharing have been reported to be associated with the development of… 
1996
1996
Cytomegalovirus (CMV) infection and HLA-DR sharing have been reported to be associated with the development of vanishing bile… 
1993
1993
SummaryIn previous studies cytomegalovirus (CMV) infection was identified as one risk factor in the development of vanishing bile…